News
BVS
13.43
-1.61%
-0.22
Weekly Report: what happened at BVS last week (0914-0918)?
Weekly Report · 2d ago
Bioventus: Cash Flow Anchors The Bull Case Beyond A Potential Sale
Seeking Alpha · 2d ago
Weekly Report: what happened at BVS last week (0907-0911)?
Weekly Report · 09/14 10:22
Weekly Report: what happened at BVS last week (0831-0904)?
Weekly Report · 09/07 10:16
Weekly Report: what happened at BVS last week (0824-0828)?
Weekly Report · 08/31 10:23
Weekly Report: what happened at BVS last week (0817-0821)?
Weekly Report · 08/24 10:24
Bioventus Earnings Call Highlights Growth Amid Review
TipRanks · 08/21 00:27
Cantor Fitzgerald Reaffirms Their Buy Rating on Bioventus (BVS)
TipRanks · 08/17 12:36
Bioventus Is Maintained at Buy by Canaccord Genuity
Dow Jones · 08/17 12:36
Bioventus Price Target Raised to $19.00/Share From $15.00 by Canaccord Genuity
Dow Jones · 08/17 12:36
Canaccord Genuity Maintains Buy on Bioventus, Raises Price Target to $19
Benzinga · 08/17 12:26
Weekly Report: what happened at BVS last week (0810-0814)?
Weekly Report · 08/17 10:25
Bioventus (BVS) Q2 2026 Earnings Call Transcript
The Motley Fool · 08/13 13:17
Weekly Report: what happened at BVS last week (0803-0807)?
Weekly Report · 08/10 10:19
Deal Dispatch: Bending Spoons Acquires Airtable, Bain Capital Buys Gong Cha Global, Salad and Go Bankruptcy
Benzinga · 08/07 17:12
Bioventus (BVS) Is Up 6.1% After Reaffirming 2026 Sales Outlook And Strong Q2 Earnings Jump
Simply Wall St · 08/07 09:31
Bioventus: Buy Rating Reaffirmed on Growth Outlook, Financial Flexibility and Strategic Review; $15 Price Target Maintained
TipRanks · 08/06 13:36
Bioventus price target raised to $18 from $16 at Craig-Hallum
TipRanks · 08/06 13:25
Biotech Stocks At 52-Week Highs - BVS, TVTX, ODTX, CRL Climb With Q2 Results, ACRS
NASDAQ · 08/06 08:54
Bioventus (BVS) Stock Jumps On Profit Strength As Growth Risks Remain
Simply Wall St · 08/06 04:50
More
Webull provides a variety of real-time BVS stock news. You can receive the latest news about Bioventus Inc. through multiple platforms. This information may help you make smarter investment decisions.
About BVS
Bioventus Inc. is a medical device company. The Company’s portfolio of products is grouped into three areas. Its Pain Treatments include the Knee Osteoarthritis (KOA) area, and Peripheral Nerve Stimulation (PNS) area. Its Surgical Solutions include Ultrasonics, which offers precision bone resection for patients with degenerative spine conditions and spinal deformities, and Bone Graft Substitutes (BGS), which includes a range of products that facilitate optimal bone fusion following a surgical procedure. Its Restorative Therapies comprise Fracture Care that provide low-intensity pulse ultrasound to help patients who suffer from bone fractures that do not heal through traditional methods. It offers a diverse portfolio of products to support physicians in relieving pain and addressing musculoskeletal challenges across indications and clinical areas, including knee, hand and upper extremities, foot and ankle, podiatry, trauma, general surgery, spine and neurosurgery.